These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
286 related items for PubMed ID: 24851468
1. Norepinephrine vs. dopamine: new recommendations for initial vasopressor selection in septic shock. Bartel B. S D Med; 2014 May; 67(5):200-1. PubMed ID: 24851468 [No Abstract] [Full Text] [Related]
2. Noradrenaline as a vasoactive agent in septic shock. Tordoff SG, Thompson JL, Williams AW. Intensive Care Med; 2000 May; 26(5):648. PubMed ID: 10923747 [No Abstract] [Full Text] [Related]
3. Recommendations for the treatment of patients with septic shock. Meier-Hellmann A, Reinhart K. Acta Anaesthesiol Scand Suppl; 1997 May; 111():177-80. PubMed ID: 9421002 [No Abstract] [Full Text] [Related]
4. Vasopressor dosing in septic shock. Alaniz C, Pollard S. Crit Care Med; 2013 Dec; 41(12):e483-4. PubMed ID: 24275412 [No Abstract] [Full Text] [Related]
5. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock. Patel GP, Grahe JS, Sperry M, Singla S, Elpern E, Lateef O, Balk RA. Shock; 2010 Apr; 33(4):375-80. PubMed ID: 19851126 [Abstract] [Full Text] [Related]
6. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study). Póvoa PR, Carneiro AH, Ribeiro OS, Pereira AC, Portuguese Community-Acquired Sepsis Study Group. Crit Care Med; 2009 Feb; 37(2):410-6. PubMed ID: 19114885 [Abstract] [Full Text] [Related]
7. Vasoactive drug support in septic shock. Dries DJ. Shock; 2006 Nov; 26(5):529-30. PubMed ID: 17047528 [No Abstract] [Full Text] [Related]
8. Vasopressors and Inotropes in Sepsis. Stratton L, Berlin DA, Arbo JE. Emerg Med Clin North Am; 2017 Feb; 35(1):75-91. PubMed ID: 27908339 [Abstract] [Full Text] [Related]
9. Vasopressors for hypotensive shock. Lampard JG, Lang E. Ann Emerg Med; 2013 Mar; 61(3):351-2. PubMed ID: 23026787 [No Abstract] [Full Text] [Related]
10. Adrenergic support in septic shock: a critical review. Póvoa P, Carneiro AH. Hosp Pract (1995); 2010 Feb; 38(1):62-73. PubMed ID: 20469626 [Abstract] [Full Text] [Related]
11. Inotrope and vasopressor therapy of septic shock. Hollenberg SM. Crit Care Clin; 2009 Oct; 25(4):781-802, ix. PubMed ID: 19892253 [Abstract] [Full Text] [Related]
12. Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials. Vasu TS, Cavallazzi R, Hirani A, Kaplan G, Leiby B, Marik PE. J Intensive Care Med; 2012 Oct; 27(3):172-8. PubMed ID: 21436167 [Abstract] [Full Text] [Related]
13. Comparison of systemic and renal effects of dopexamine and dopamine in norepinephrine-treated septic shock. Schmoelz M, Schelling G, Dunker M, Irlbeck M. J Cardiothorac Vasc Anesth; 2006 Apr; 20(2):173-8. PubMed ID: 16616656 [Abstract] [Full Text] [Related]
14. Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? De Backer D, Creteur J, Silva E, Vincent JL. Crit Care Med; 2003 Jun; 31(6):1659-67. PubMed ID: 12794401 [Abstract] [Full Text] [Related]
15. Inotrope and vasopressor therapy of septic shock. Hollenberg SM. Crit Care Nurs Clin North Am; 2011 Mar; 23(1):127-48. PubMed ID: 21316572 [Abstract] [Full Text] [Related]
16. Norepinephrine in fluid-refractory catecholamine-resistant cold shock: are we sure? Silvani P. Crit Care Med; 2009 Jul; 37(7):2322-3; author reply 2323. PubMed ID: 19535935 [No Abstract] [Full Text] [Related]
20. Practice Patterns and Outcomes Associated With Choice of Initial Vasopressor Therapy for Septic Shock. Fawzy A, Evans SR, Walkey AJ. Crit Care Med; 2015 Oct; 43(10):2141-6. PubMed ID: 26079345 [Abstract] [Full Text] [Related] Page: [Next] [New Search]